Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Sub-study 1 – Healthy participants:
- People aged 23 to 50 years
- People with a body mass index (a measure of body weight relative to height) between 20.0 and 26.9
- People with a blood sugar control measure (HbA1c) below 42 mmol/mol, indicating no diabetes
- People who are able to give their consent to take part
Sub-study 2 – People with Type 2 Diabetes:
- People aged 23 to 60 years
- People who have been diagnosed with type 2 diabetes for at least 3 months
- People with a blood sugar control measure (HbA1c) above 53 mmol/mol
- People who are managed with metformin as their only diabetes medication
- People who are able to give their consent to take part
Sub-study 2 – Healthy comparison participants:
- People aged 23 to 64 years
- People with a blood sugar control measure (HbA1c) below 42 mmol/mol, indicating no diabetes
- People who are able to give their consent to take part
Who may not be able to join:
- People who have anaemia (low red blood cell levels or low haemoglobin)
- People with elevated liver enzyme levels (ALT more than twice the upper normal limit), or any known liver, gallbladder, or digestive tract condition
- People with kidney disease, indicated by elevated creatinine levels in the blood
- People who have previously had surgery to remove part of the stomach or intestines (except removal of the appendix or gallbladder), or any major abdominal surgery including weight-loss surgery
- People with type 1 or type 2 diabetes, or a blood sugar control measure at or above 42 mmol/mol — applies to Sub-study 1 only
- People taking any blood sugar-lowering medication other than metformin — applies to Sub-study 2 only
- People with a chronic lung condition called COPD (chronic obstructive pulmonary disease) — applies to Sub-study 2 only
- People who regularly smoke or use any nicotine-containing products
- People who experience claustrophobia (fear of enclosed spaces)
- People who are pregnant, breastfeeding, or planning to become pregnant during the study
- People who have recently started a special diet, made major lifestyle changes, or lost more than 5% of their body weight in the 3 months before or during the study
- People taking any medication, or living with any physical or psychological condition, that the trial team considers may affect their ability to participate (confirm with trial site)
- People who are not able to speak or read Danish
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +4535454498
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Metabolic Rate of FDG
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.